Showing 3361-3370 of 10618 results for "".
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
https://reachmd.com/programs/cme/advancing-clinical-expertise-in-celmods-transforming-multiple-myeloma-treatment/35631/This activity will cultivate familiarity with the emerging CELMoD treatment class poised to transform the management of newly-diagnosed and R/R MM. With a higher affinity for cereblon than their predecessors, CELMoDs represent a new, distinct generation of immunomodulatory drugs with the potential tSigns of Progress: PED as a Predictor of Disease and Outcomes
https://reachmd.com/specialty/general-ophthalmology/Signs-of-Progress-PED-as-a-Predictor-of-Disease-and-Outcomes-2510/33107/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.The Durability Dilemma
https://reachmd.com/specialty/general-ophthalmology/The-Durability-Dilemma-2510/33129/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Fluid Foundations: How Location Impacts Outcomes in nAMD
https://reachmd.com/programs/cme/Fluid-Foundations-How-Location-Impacts-Outcomes-in-nAMD-2510/33126/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Predicting Durability: Where Are We Now?
https://reachmd.com/programs/cme/Predicting-Durability-Where-Are-We-Now-2510/33131/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Real-World Adaptation of Trial Protocols
https://reachmd.com/specialty/general-ophthalmology/Real-World-Adaptation-of-Trial-Protocols-2510/33130/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Biomarking the Difference: How Second-Generation Therapies are Changing the Game
https://reachmd.com/programs/cme/Biomarking-the-Difference-How-Second-Generation-Therapies-are-Changing-the-Game-2510/32736/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Early Fluid Resolution – A Key to Long-Term Success
https://reachmd.com/specialty/general-ophthalmology/Early-Fluid-Resolution-A-Key-to-Long-Term-Success-2510/33128/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Beyond Durability - What Biomarkers Reveal About Disease Control
https://reachmd.com/programs/cme/Beyond-Durability-What-Biomarkers-Reveal-About-Disease-Control-2510/33104/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.Second-Generation Biomarkers for Treatment Outcomes
https://reachmd.com/programs/cme/Second-Generation-Biomarkers-for-Treatment-Outcomes-2510/33097/Hear about new biomarkers for assessing retinal disease activity and their clinical significance when using of second-generation agents.